Related references
Note: Only part of the references are listed.Establishment of a transgenic mouse to model ETV7 expressing human tumors
Masashi Numata et al.
TRANSGENIC RESEARCH (2019)
The opposing effects of interferon-beta and oncostatin-M as regulators of cancer stem cell plasticity in triple-negative breast cancer
Mary R. Doherty et al.
BREAST CANCER RESEARCH (2019)
ABCC1-Exported Sphingosine-1-phosphate, Produced by Sphingosine Kinase 1, Shortens Survival of Mice and Patients with Breast Cancer
Akimitsu Yamada et al.
MOLECULAR CANCER RESEARCH (2018)
CRISPOR: intuitive guide selection for CRISPR/Cas9 genome editing experiments and screens
Jean-Paul Concordet et al.
NUCLEIC ACIDS RESEARCH (2018)
ETV7-Mediated DNAJC15 Repression Leads to Doxorubicin Resistance in Breast Cancer Cells
Federica Alessandrini et al.
NEOPLASIA (2018)
ETV7 is an essential component of a rapamycin-insensitive mTOR complex in cancer
Franklin C. Harwood et al.
SCIENCE ADVANCES (2018)
The regulation of interferon type I pathway-related genes RSAD2 and ETV7 specifically indicates antibody-mediated rejection after kidney transplantation
Mareen Matz et al.
CLINICAL TRANSPLANTATION (2018)
Revisiting the role of ABC transporters in multidrug-resistant cancer
Robert W. Robey et al.
NATURE REVIEWS CANCER (2018)
Interferon-beta represses cancer stem cell properties in triple-negative breast cancer
Mary R. Doherty et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
The molecular mechanisms of chemoresistance in cancers
Hua-Chuan Zheng
ONCOTARGET (2017)
The ETS family of oncogenic transcription factors in solid tumours
Gina M. Sizemore et al.
NATURE REVIEWS CANCER (2017)
TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data
Antonio Colaprico et al.
NUCLEIC ACIDS RESEARCH (2016)
ETS transcription factors in embryonic vascular development
Michael P. Craig et al.
ANGIOGENESIS (2016)
Surfactant Protein A Prevents IFN-γ/IFN-γ Receptor Interaction and Attenuates Classical Activation of Human Alveolar Macrophages
Carlos M. Minutti et al.
JOURNAL OF IMMUNOLOGY (2016)
IFN-γ Induces Histone 3 Lysine 27 Trimethylation in a Small Subset of Promoters to Stably Silence Gene Expression in Human Macrophages
Yu Qiao et al.
CELL REPORTS (2016)
Cancer Stem Cell Plasticity Drives Therapeutic Resistance
Mary R. Doherty et al.
CANCERS (2016)
ELF5 isoform expression is tissue-specific and significantly altered in cancer
Catherine L. Piggin et al.
BREAST CANCER RESEARCH (2016)
The origin of breast tumor heterogeneity
A. Skibinski et al.
ONCOGENE (2015)
Cancer Stem Cells: The Promise and the Potential
Jaffer A. Ajani et al.
SEMINARS IN ONCOLOGY (2015)
Cancer stem cell targeted therapy: progress amid controversies
Tao Wang et al.
ONCOTARGET (2015)
Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas
Yari Ciribilli et al.
ONCOTARGET (2015)
TEL2 suppresses metastasis by down-regulating SERPINE1 in nasopharyngeal carcinoma
Yi Sang et al.
ONCOTARGET (2015)
Mammosphere Formation Assay from Human Breast Cancer Tissues and Cell Lines
Ylenia Lombardo et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2015)
The Molecular Signatures Database Hallmark Gene Set Collection
Arthur Liberzon et al.
CELL SYSTEMS (2015)
Cancer stem cell plasticity and tumor hierarchy
Marina Carla Cabrera et al.
WORLD JOURNAL OF STEM CELLS (2015)
Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer
Matthew D. Burstein et al.
CLINICAL CANCER RESEARCH (2015)
featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
Yang Liao et al.
BIOINFORMATICS (2014)
Is the differentiation into molecular subtypes of breast cancer important for staging, local and systemic therapy, and follow up?
Amir Sonnenblick et al.
CANCER TREATMENT REVIEWS (2014)
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu et al.
NATURE MEDICINE (2014)
Easy quantitative assessment of genome editing by sequence trace decomposition
Eva K. Brinkman et al.
NUCLEIC ACIDS RESEARCH (2014)
Alteration of gene expression and DNA methylation in drug-resistant gastric cancer
Osamu Maeda et al.
ONCOLOGY REPORTS (2014)
ΔN-P63a and TA-P63a exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites
Paola Monti et al.
ONCOTARGET (2014)
Cooperative interactions between p53 and NFκB enhance cell plasticity
Alessandra Bisio et al.
ONCOTARGET (2014)
Breast Cancer Stem Cells Transition between Epithelial and Mesenchymal States Reflective of their Normal Counterparts
Suling Liu et al.
STEM CELL REPORTS (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Molecular mechanisms of ETS transcription factor-mediated tumorigenesis
Adwitiya Kar et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2013)
Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code
Yari Ciribilli et al.
NUCLEIC ACIDS RESEARCH (2013)
P53 Family Members Modulate the Expression of PRODH, but Not PRODH2, via Intronic p53 Response Elements
Ivan Raimondi et al.
PLOS ONE (2013)
The ETS Transcription Factor ETV7 Exhausts Hematopoietic Stem Cells By Enhancing The Cell Cycle Entry and Cell Proliferation
Masashi Numata et al.
BLOOD (2013)
A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis
Swarnali Acharyya et al.
CELL (2012)
Cancer stem cells
Zuoren Yu et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Multiple roles of the epithelium-specific ETS transcription factor, ESE-1, in development and disease
Jordan R. Oliver et al.
LABORATORY INVESTIGATION (2012)
clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters
Guangchuang Yu et al.
OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY (2012)
Strategies for subtypes-dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2011)
edgeR: a Bioconductor package for differential expression analysis of digital gene expression data
Mark D. Robinson et al.
BIOINFORMATICS (2010)
ABC transporters in cancer: more than just drug efflux pumps
Jamie I. Fletcher et al.
NATURE REVIEWS CANCER (2010)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy
Christine M. Fillmore et al.
BREAST CANCER RESEARCH (2008)
Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer
Scott A. Tomlins et al.
NATURE (2007)
ETS transcription factors and their emerging roles in human cancer
A Seth et al.
EUROPEAN JOURNAL OF CANCER (2005)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis
M Cardone et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Mechanisms of Drug Resistance in Cancer Chemotherapy
Y. A. Luqmani
MEDICAL PRINCIPLES AND PRACTICE (2005)
TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 cells and blocks the inhibitory effect of TEL1 on Ras-induced cellular transformation
H Kawagoe et al.
CANCER RESEARCH (2004)
Role of cell cycle in mediating sensitivity to radiotherapy
TM Pawlik et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Death and anti-death: Tumour resistance to apoptosis
FH Igney et al.
NATURE REVIEWS CANCER (2002)
The ETS-domain transcription factor family
AD Sharrocks
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Tel-2 is a novel transcriptional repressor related to the Ets factor Tel/ETV-6
XS Gu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Mouse models in the study of the Ets family of transcription factors
FO Bartel et al.
ONCOGENE (2000)
Share Paper
